Dysosteosclerosis presents as an "Osteoclast-Poor" form of osteopetrosis: Comprehensive investigation of a 3-year-old girl and literature review

Journal of Bone and Mineral Research

Volumn 25, Issue 11, 2010, Pages 2527-2539

  Whyte, Michael P ^a,b   Wenkert, Deborah ^a   McAlister, William H ^c   Novack, Deborah V ^b   Nenninger, Angie R ^a   Zhang, Xiafang ^b   Huskey, Margaret ^b   Mumm, Steven ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

bone remodeling; erlenmeyer flask deformity; osteoclast; osteosclerosis; RANKL; skeletal dysplasia

Indexed keywords

BIOLOGICAL FACTOR; CHLORIDE CHANNEL; CHLORIDE CHANNEL 7 PROTEIN; DEMECLOCYCLINE; MEMBRANE PROTEIN; MONOCYTE COLONY STIMULATING FACTOR; OPT ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARACETAMOL; PARATHYROID HORMONE; PROTEIN C FMS; PROTEIN OPG; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; REGULATOR PROTEIN; T CELL IMMUNE REGULATOR 1; UNCLASSIFIED DRUG; VITAMIN D;

ALBERS SCHOENBERG DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ALTERNATIVE RNA SPLICING; ARTICLE; BONE; CALCIUM INTAKE; CASE REPORT; CHILD; DYSOSTEOSCLEROSIS; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; FRONTAL BOSSING; GENE MUTATION; HEAD CIRCUMFERENCE; HORMONE BLOOD LEVEL; HUMAN; ILIAC CREST; LIMB FRACTURE; METAPHYSIS; MICROARRAY ANALYSIS; OSTEOCLAST; OSTEOPENIA; OSTEOSCLEROSIS; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PELVIS; PRESCHOOL CHILD; RADIOGRAPHY; RIB FRACTURE; RICKETS; SCLERA; SCLEROSIS; TOOTH; VALGUS KNEE;

ADULT; BONE AND BONES; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; OSTEOCLASTS; OSTEOPETROSIS; OSTEOSCLEROSIS; PREGNANCY; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78349245880     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.131     Document Type: Article

References (52)

1. Online Mendelian Inheritance in Man (OMIM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), November 11, 2009
2. Spranger J, Albrecht C, Rohwedder HJ, Wiedemann HR,. Dysosteosclerosis: a special form of generalized osteosclerosis. Fortschr Geb Rontgenstr Nuklearmed. 1968; 109: 504 -512.
3. Whyte MP,. Osteopetrosis. In:, Royce PM, Steinmann B, eds. Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects, 2nd ed. New York: Wiley-Liss; 2002: 789 -807.
4. Leisti J, Kaitila I, Lachman RS, Asch MJ, Rimoin DL,. Dysosteosclerosis. Birth Defects. 1975; 11: 349 -351.
5. Kaitila I, Rimoin DL,. Histologic heterogeneity in the hyperostotic bone dysplasias. Birth Defects. 1976; 21: 71 -79.
6. Houston CS, Gerrard JW, Ives EJ,. Dysosteosclerosis. Am J Roentgen. 1978; 130: 988 -991.
7. Packota GV, Shiffman J, Hall JM,. Osteomyelitis of the mandible in a patient with dysosteosclerosis. Oral Surg, Oral Med, Oral Path. 1991; 71: 144 -147.
8. Lachman RS,. Dysosteosclerosis. In: Taybi and Lachman's: Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias, 5th ed. St. Louis, MO, Mosby; 2007: 938 -939.
9. Spranger JW, Brill PW, Poznanski A,. Dysosteosclerosis. In: Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, 2nd ed. New York, NY: Oxford University Press; 2002: 476 -479.
10. Sener RN, Yalman O, Cetingul N, Tutuncuoglu S, Kavakli K, Ustun EE,. Dysosteosclerosis: clinicoradiologic findings including brain MRI. Comput Med Imaging Graph. 1997; 21: 355 -357.
11. Pascual-Castroviejo I, Casas-Fernandez C, Lopez-Martin V, Martinez-Bermejo A,. X-linked dysosteosclerosis. Four familial cases. Eur J Pediatr. 1997; 126: 127 -138.
12. Ellis RWB,. Osteopetrosis. Proc Roy Soc Med. 1934; 27: 1563.
13. Field CE,. Albers-Schönberg Disease. An atypical case. Proc Roy Soc Med. 1938; 30: 320.
14. Roy C, Maroeaux P, Kremp L, Courtecuisse V, Alagille D,. Un nouveau syndrome osseux avec anomalies cutanées et troubles neurologiques. Arch Fr Pediatr. 1968; 25: 893 -905.
15. Johns E, Kozlowski K, Masel J, Muralinath S, Vijayalaskshmi G,. Dysosteosclerosis. Australas Radiol. 1998; 40: 345 -347.
16. Lemire EG, Wiebe W,. Clinical and radiologic findings in an adult male with dysosteoslcerosis. Am J Med Genet. 2007; 146A: 474 -478.
17. Whyte MP, Kempa L, McAlister WH, Zhang F, Mumm S, Wenkert D,. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (chloride channel 7 deficiency osteopetrosis) among the sclerosing bone disorders. J Bone Miner Res 2010; 25: 2515 -2526.
18. Whyte MP, Chines A, Silva DP, Landt Y, Ladenson JH,. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders. J Bone Miner Res. 1996; 11: 1438 -1443.
19. Hughes AE, Ralston SH, Marken J, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 2000; 24: 45 -48.
20. Whyte MP, O'Brecht SE, Finnegan PM, et al. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med. 2002; 347: 175 -184.
21. Sobacchi C, Frattini A, Guerrini MM, et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nature Genet. 2007; 39: 960 -962.
22. Nürnberg P, Thiele H, Chandler D, et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet. 2001; 28: 37 -41.
23. Turan S, Bereket A, Omar A, Berber M, Ozen A, Bekiroglu N,. Upper segment/lower segment ratio and armspan-height difference in healthy Turkish children. Acta Paediatr. 2005; 94: 407 -413.
24. Martin RP, Deane RH, Collett V,. Spondylolysis in children who have osteopetrosis. J Bone Joint Surg Am. 1997; 79: 1685 -1689.
25. Connective Tissue Gene Tests (Allentown, PA).
26. Xiong DH, Shen H, Zhao LJ, et al. Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res. 2006; 21: 1678 -1695.
27. Hsu YH, Niu T, Terwedow HA, et al. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum Genet. 2006; 118: 568 -577.
28. Whyte MP, Totty WG, Novack DV, Wenkert D,., Zhang X, Mumm S,. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 with a missense change in TNFSF11 encoding RANK ligand. J Bone Miner Res. (in press).
29. Key L, Carnes D, Cole S, et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med. 1984; 310: 409 -415.
30. Elçioglu NH, Vellodi A, Hall CM,. Dysosteosclerosis: A report of three new cases and evaluation of the radiological findings. J Med Genet. 2002; 39: 603 -607.
31. Fryns JP, Vinken L, Claessens S, Marien J, Geutiens J, Van den Berghe H,. Dysosteosclerosis in a mentally retarded boy. Acta Paediatr Belg. 1980; 33: 53 -56.
32. Greenspan A,. Sclerosing bone dysplasias-a target-site approach. Skeletal Radiol. 1991; 20: 561 -583.
33. Canepa G, Maroteaux P, Pietrogrande V,. Dysmorphic Syndromes and Constitutional Diseases of the Skeleton. Piccin Nuova Libraria S.p.A, Padova, Italy: 2001.
34. Oncag O, Ozkinay FF, Eronat C,. A case with unique dental findings and SEM evaluation of a hypoplastic tooth. J Clin Pediatr Dent. 1999; 23: 347 -352.
35. Stehr L,. Pathogenese und Klassifikation der Osteoskleresen. Arch Orthop Unfall-Chir. 1942; 41: 156.
36. Chitavat D, Silver K, Azous EM,. Skeletal dysplasia, intracerebral calcifications, optic atrophy, hearing impairment, and mental retardation: nosology of dysosteosclerosis. Am J Med Genet. 1992; 43: 517 -523.
37. Maheshwari A, Rao KK, Kohli N,. Case report: dysosteosclerosis: a unique entity. Clin Radiol. 1996; 51: 224 -228.
38. Alagille D,. Persönl. Mittlg. Von P. Maroteaux, Paris.
39. Utz VW,. Manifesetation der Dysosteosklerose in Kieferbe-reich. Dtsch Zahnaerztl Z. 1970; 25: 48 -50.
40. Bartuseviciene A, Samuilis A, Skucas J,. Camurati-Engelmann disease: imaging, clinical features and differential diagnosis. Skeletal Radiol. 2009; 38: 1037 -1043.
41. Superti-Furga A, Unger S, and the Nosology Group of the International Skeletal Dysplasia Society. Nosology and classification of genetic skeletal disorders: 2006 version. Am J Med Genet Part A. 2007; 143A: 1 -18.
42. th Ed)., Rosen CJ, Compston JE, Lian JB, eds, Washington, DC: The American Society for Bone and Mineral Research; 2008, p. 413.
43. Faden MA, Krakow D, Ezgu F, Rimoin DL, Lachman RS,. The Erlenmeyer flask bone deformity in the skeletal dysplasias. Am J Med Genet. 2009; 149A: 1334 -1345.
44. Tolar J, Teitelbaum SL, Orchard PJ,. Osteopetrosis. N Engl J Med. 2004; 351: 2839 -2849.
45. Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C,. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009; 84: 1 -12.
46. Whyte MP, Murphy WA, Fallon MD, et al. Osteopetrosis, renal tubular acidosis, and basal ganglia calcification in three sisters. Am J Med. 1980; 69: 64 -74.
47. Guerrini MM, Sobacchi C, Cassani B, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008; 83: 64 -76.
48. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990; 345: 442 -444. (Pubitemid 120014957)
49. Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, et al. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet. 2009; 124: 561 -577.
50. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G,. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone. 1998; 23: 187 -196.
51. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L,. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 1998; 17: 4668 -4679.
52. Soedarsono N, Rabello D, Kamei H, et al. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis. J Periodontal Res. 2006; 41: 397 -404. (Pubitemid 44337254)